Chronic administration of galanin attenuates the TNBS-induced colitis in rats

Regulatory Peptides

Volumn 141, Issue 1-3, 2007, Pages 96-104

  Talero, E ^a   Sanchez Fidalgo S ^a   Calvo, J R ^b   Motilva, V ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

Author keywords

COX 2; Galanin; IBD; Inflammatory colitis; iNOS; Mast cell; Peptides; TNBS

Indexed keywords

GALANIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRITE; SULFONIC ACID DERIVATIVE; TOLONIUM CHLORIDE; TRINITROBENZENSULFONIC ACID; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DRUG INSTILLATION; ENTERITIS; FEMALE; HISTOLOGY; INFLAMMATION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; STAINING; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; COLITIS; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GALANIN; INJECTIONS, INTRAPERITONEAL; MALE; MAST CELLS; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; PEROXIDASE; RATS; RATS, WISTAR; TIME FACTORS; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; RATTUS;

EID: 33947591092     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.12.029     Document Type: Article

References (57)

1. Fiocchi C. Inflammatory bowel disease. Current concepts of pathogenesis and implications for therapy. Minerva Gastroenterol Dietol 48 (2002) 215-226
2. Lin T.J., and Befus A.D. Mast cells in mucosal defences and pathogenesis. In: Ogra P.L., Mestecky J., Lamm M.E., Strober W., McGhee J.R., and Bienenstock J. (Eds). Mucosal immunology. 3rd edn. (2004), Academic Press, San Diego 703-715
3. Vliagoftis H., and Befus A.D. Mast cells at mucosal frontiers. Curr Mol Med 5 (2005) 573-589
4. Iba Y., Sugimoto Y., Kamei C., and Masukawa T. Possible role of mucosal mast cells in the recovery process of colitis induced by dextran sulfate sodium in rats. Int Immunopharmacol 3 (2003) 485-491
5. Santos J., Guilarte M., Alonso C., and Malagelada J.R. Pathogenesis of irritable bowel syndrome: the mast cell connection. Scand J Gastroenterol 40 (2005) 129-140
6. Fukumoto Y., Kasai H., Takahashi H., Sugiyama H., Hase N., Kaneko H., et al. The role of mast cells in the development of 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in rats. Scand J Gastroenterol 37 (2002) 555-560
7. Araki Y., Andoh A., Fujiyama Y., and Bamba T. Development of dextran sulphate sodium-induced experimental colitis is suppressed in genetically mast cell-deficient Ws/Ws rats. Clin Exp Immunol 119 (2000) 264-269
8. Middleton S.J., Shorthouse M., and Hunter J.O. Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leucocytes. Gut 34 (1993) 814-817
9. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 305 (1994) 253-264
10. Ribbons K.A., Zhang X.J., Thompson J.H., Greenberg S.S., Moore W.M., Kornmeier C.M., et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 108 (1995) 705-711
11. Kolios G., Valatas V., and Ward S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 113 (2004) 427-437
12. Miampamba M., and Sharkey K.A. Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol Motil 10 (1998) 315-329
13. Reinshagen M., Flamig G., Ernst S., Geerling I., Wong H., Walsh J.H., et al. Calcitonin gene-related peptide mediates the protective effect of sensory nerves in a model of colonic injury. J Pharmacol Exp Ther 286 (1998) 657-661
14. Gulluoglu B.M., Kurtel H., Gulluoglu M.G., Aktan A.O., Yegen B.C., Dizdaroglu F., et al. Bombesin ameliorates colonic damage in experimental colitis. Dig Dis Sci 44 (1999) 1531-1538
15. Castagliuolo I., Morteau O., Keates A.C., Valenick L., Wang C.C., Zacks J., et al. Protective effects of neurokinin-1 receptor during colitis in mice: role of the epidermal growth factor receptor. Br J Pharmacol 136 (2002) 271-279
16. Yegen B.C. Bombesin-like peptides: candidates as diagnostic and therapeutic tools. Curr Pharm Des 9 (2003) 1013-1022
17. Abad C., Martinez C., Juarranz M.G., Arranz A., Leceta J., Delgado M., et al. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterology 124 (2003) 961-971
18. Tatemoto K., Rökaeus A., Jörnvall H., McDonald T.J., and Mutt V. Galanin, a novel biologically active peptide from porcine intestine. FEBS Lett 164 (1983) 124-128
19. Anselmi L., Lakhter A., Hirano A.A., Tonini M., and Sternini C. Expression of galanin receptor messenger RNAs in different regions of the rat gastrointestinal tract. Peptides 26 (2005) 815-819
20. Bauer F.E., Zintel A., Kenny M.J., Calder D., Ghatei M.A., and Bloom S.R. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 97 (1989) 260-264
21. Nagase H., Nakajima A., Sekihara H., York D.A., and Bray G.A. Regulation of feeding behavior, gastric emptying, and sympathetic nerve activity to interscapular brown adipose tissue by galanin and enterostatin: the involvement of vagal-central nervous system interactions. J Gastroenterol 37 Suppl 14 (2002) 118-127
22. Branchek T.A., Smith K.E., Gerald C., and Walker M.W. Galanin receptor subtypes. Trends Pharmacol Sci 21 (2000) 109-117
23. Gu Z.F., Pradhan T.K., Coy D.H., and Jensen R.T. Interaction of galanin fragments with galanin receptors on isolated smooth muscle cells from Guinea pig stomach: identification of a novel galanin receptor subtype. J Pharmacol Exp Ther 272 (1995) 371-378
24. Benya R.V., Marrero J.A., Ostrovskiy D.A., Koutsouris A., and Hecht G. Human colonic epithelial cells express galanin-1 receptors, which when activated cause Cl-secretion. Am J Physiol 276 (1999) G64-G72
25. Talero E., Sánchez-Fidalgo S., Calvo J.R., and Motilva V. Galanin in the trinitrobenzene sulfonic acid rat model of experimental colitis. Int Immunopharmacol 6 (2006) 1404-1412
26. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., and Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989) 795-803
27. Bobin-Dubigeon C., Collin X., Grimaud N., Robert J.M., Le Baut G., and Petit J.Y. Effects of tumour necrosis factor-α synthesis inhibitors on rat trinitrobenzene sulphonic acid-induced chronic colitis. Eur J Pharmacol 421 (2001) 103-110
28. Grisham M.B., Beniot J.N., and Granger D.N. Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol 186 (1990) 729-742
29. Ji R.R., Zhang X., Zhang Q., Dagerlind A., Nilsson S., Wiesenfeld-Hallin Z., et al. Central and peripheral expression of galanin in response to inflammation. Neuroscience 68 (1995) 563-576
30. Qinyang W., Hultenby K., Adlan E., and Lindgren J.U. Galanin in adjuvant arthritis in the rat. J Rheumatol 31 (2004) 302-307
31. Shanahan F., Denburg J.A., Fox J., Bienenstock J., and Befus D. Mast cell heterogeneity: effects of neuroenteric peptides on histamine release. J Immunol 135 (1985) 1331-1337
32. Stoyanova I.I., and Gulubova M.V. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem 104 (2002) 185-192
33. Soderholm J.D., Yang P.C., Ceponis P., Vohra A., Riddell R., Sherman P.M., et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 123 (2002) 1099-1108
34. Montemurro P., Nishioka H., Dundon W.G., de Bernard M., Del Giudice G., Rappuoli R., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 32 (2002) 671-676
35. Wei O.L., Hilliard A., Kalman D., and Sherman M. Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium. Infect Immun 73 (2005) 1978-1985
36. Artuc M., Hermes B., Steckelings U.M., Grutzkau A., and Henz B.M. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders?. Exp Dermatol 8 (1999) 1-16
37. Gelbmann C.M., Mestermann S., Gross V., Kollinger M., Scholmerich J., and Falk W. Strictures in Crohn's disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 45 (1999) 210-217
38. Bjorkqvist M., Bernsand M., Eliasson L., Hakanson R., and Lindstrom E. Somatostatin, misoprostol and galanin inhibit gastrin- and PACAP-stimulated secretion of histamine and pancreastatin from ECL cells by blocking specific Ca2+ channels. Regul Pept 130 (2005) 81-90
39. Zeng N., Kang T., Wen Y., Wong H., Walsh J., and Sachs G. Galanin inhibition of enterochromaffin-like cell function. Gastroenterology 115 (1998) 330-339
40. Lindstrom E., and Hakanson R. Neurohormonal regulation of secretion from isolated rat stomach ECL cells: a critical reappraisal. Regul Pept 97 (2001) 169-180
41. Martin A.R., Villegas I., Sanchez-Hidalgo M., and de la Lastra C.A. The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br J Pharmacol 147 (2006) 873-885
42. Cox D.G., Crusius J.B., Peeters P.H., Bueno-de-Mesquita H.B., Pena A.S., and Canzian F. Haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease. World J Gastroenterol 11 (2005) 6003-6008
43. Eberhart C.E., Coffey R.J., Radhika A., Giardiello F.M., Ferrenbach S., and DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107 (1994) 1183-1188
44. El Miedany Y., Youssef S., Ahmed I., and El Gaafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol 101 (2006) 311-317
45. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., Su L.K., and Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342 (2000) 1946-1952
46. Martin M.J., Jimenez M.D., and Motilva V. New issues about nitric oxide and its effects on the gastrointestinal tract. Curr Pharm Des 7 (2001) 881-908
47. Van der Woude C.J., Kleibeuker J.H., Jansen P.L., and Moshage H. Chronic inflammation, apoptosis and (pre-)malignant lesions in the gastro-intestinal tract. Apoptosis 9 (2004) 123-130
48. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 38 (2003) 421-430
49. Vittoria A., Costagliola A., Carrese E., Mayer B., and Cecio A. Nitric oxide-containing neurons in the bovine gut, with special reference to their relationship with VIP and galanin. Arch Histol Cytol 63 (2000) 357-368
50. Singaram C., Sengupta A., Sweet M.A., Sugarbaker D.J., and Goyal R.K. Nitrinergic and peptidergic innervation of the human oesophagus. Gut 35 (1994) 1690-1696
51. Rumi G., Tsubouchi R., Nishio H., Kato S., Mozsik G., and Takeuchi K. Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J Physiol Pharmacol 55 (2004) 823-836
52. Hollander D. Inflammatory bowel diseases and brain-gut axis. J Physiol Pharmacol 54 (2003) 183-190
53. Nanetti L., Vignini A., Moroni C., Bartolini M., Luzzi S., Provinciali L., et al. Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from Alzheimer patients. Brain Res 1054 (2005) 38-44
54. Madrigal J.L., Garcia-Bueno B., Moro M.A., Lizasoain I., Lorenzo P., and Leza J.C. Relationship between cyclooxygenase-2 and nitric oxide synthase-2 in rat cortex after stress. Eur J Neurosci 18 (2003) 1701-1705
55. Brewer A., Echevarria D.J., Langel U., and Robinson J.K. Assessment of new functional roles for galanin in the CNS. Neuropeptides 39 (2005) 323-326
56. Saito J., Ozaki Y., Kawasaki M., Ohnishi H., Okimoto N., Nakamura T., and Ueta Y. Induction of galanin-like peptide gene expression in the arcuate nucleus of the rat after acute but not chronic inflammatory stress. Mol Brain Res 133 (2005) 233-241
57. Maunder R. Mediators of stress effects in inflammatory bowel disease: not the usual suspects. J Psychosom Res 48 (2000) 569-577